Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 39 (1) , 32-40
- https://doi.org/10.1053/shem.2002.29251
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxisBone Marrow Transplantation, 1999
- Infections in adults undergoing unrelated donor bone marrow transplantationBritish Journal of Haematology, 1999
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Bone marrow transplantation across HLA barriers by increasing the number of transplanted cellsImmunology Today, 1995
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- Presentation and recognition of major and minor histocompatibility antigensTransplant Immunology, 1994
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993
- DRUG-INDUCED IN VITRO TOLERANCE TO ALLOGENEIC ANTIGENSTransplantation, 1988
- 1. Establishment of a Tolerance Industion System in a Fully Allogeneic Murine CombinationTransplantation, 1986